Back to Search Start Over

Vaccine response after pneumococcal vaccination in allogeneic hematopoietic stem cell transplant recipients.

Authors :
Cheplowitz, Halle
Patel, Nimish
Kim, Alexander
Logan, Cathy
Law, Nancy
Koura, Divya
Haste, Nina
Medley, Katherine
Trinh, Julie
Sanders, Tyler
Taremi, Mahnaz
Saunders, Ila M
Source :
Journal of Oncology Pharmacy Practice. Jan2024, Vol. 30 Issue 1, p15-18. 4p.
Publication Year :
2024

Abstract

Current guidelines for vaccination in allogeneic hematopoietic stem cell transplant (HCT) recipients recommend initiation of pneumococcal vaccination series three to six months post-HCT, with most data supporting initiation at six months due to a more robust immune response. This single-center, retrospective, observational chart review aimed to evaluate the impact of initiating the pneumococcal vaccine series at three months post-HCT compared to six months post-HCT. The primary endpoints were defined as a percentage of patients with a serologic response of >1 and >1.3 µg/mL for over 50% of the defined serotypes. Outcomes showed no difference in immunologic response between the two groups. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10781552
Volume :
30
Issue :
1
Database :
Academic Search Index
Journal :
Journal of Oncology Pharmacy Practice
Publication Type :
Academic Journal
Accession number :
174972713
Full Text :
https://doi.org/10.1177/10781552231165733